Automate Your Wheel Strategy on UNH
With Tiblio's Option Bot, you can configure your own wheel strategy including UNH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNH
- Rev/Share 464.6352
- Book/Share 115.1473
- PB 3.3172
- Debt/Equity 0.836
- CurrentRatio 0.8458
- ROIC 0.1255
- MktCap 312729102713.0
- FreeCF/Share 27.7703
- PFCF 12.375
- PE 14.755
- Debt/Assets 0.2566
- DivYield 0.025
- ROE 0.226
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | UNH | Robert W. Baird | Neutral | Underperform | -- | $198 | July 31, 2025 |
| Reiterated | UNH | Oppenheimer | -- | Outperform | $400 | $325 | July 30, 2025 |
| Downgrade | UNH | Robert W. Baird | Outperform | Neutral | -- | $312 | June 11, 2025 |
| Downgrade | UNH | HSBC Securities | Hold | Reduce | -- | $270 | May 21, 2025 |
| Downgrade | UNH | TD Cowen | Buy | Hold | -- | $308 | May 19, 2025 |
| Downgrade | UNH | Raymond James | Strong Buy | Market Perform | -- | -- | May 14, 2025 |
| Downgrade | UNH | BofA Securities | Buy | Neutral | -- | $350 | May 14, 2025 |
| Downgrade | UNH | HSBC Securities | Buy | Hold | -- | $490 | April 22, 2025 |
| Downgrade | UNH | Argus | Buy | Hold | -- | -- | April 21, 2025 |
| Upgrade | UNH | HSBC Securities | Hold | Buy | -- | $595 | Jan. 10, 2025 |
News
Wall Street Analysts Think UnitedHealth (UNH) Is a Good Investment: Is It?
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
UnitedHealth vs. Molina: Who's Poised for the Healthiest Comeback?
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Negative
The U.S. healthcare sector is navigating a turbulent landscape, shaped by rising medical costs, regulatory scrutiny and evolving patient behavior. Health insurers are under pressure as increasing utilization and reimbursement challenges test margins.
Read More
Buy or Fear UNH Stock At $345?
Published: September 26, 2025 by: Forbes
Sentiment: Positive
UnitedHealth Group stock (NYSE: UNH) is up 16% this month, driven by several positive factors. Last month, Warren Buffett disclosed a $1.6 billion stake in the company.
Read More
UnitedHealth Group: Berkshire Position Marks A Salad Oil Moment
Published: September 23, 2025 by: Seeking Alpha
Sentiment: Neutral
Recently, several high-profile institutional investors, including Berkshire Hathaway, disclosed new stakes in UnitedHealth Group Incorporated shares. This reminds me of America Express during the salad oil scandal in early 1960s, which was a definitive episode for the path of Warren Buffett and Berkshire Hathaway. I see fundamental similarities here with both company facing large uncertainties and large price/valuation compression, while the outcomes of their legal issues are still unfolding.
Read More
UnitedHealth: I Can Confidently Say The Worst Is Arguably Over (Upgrade)
Published: September 23, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group investors have continued to outperform the S&P 500 and the healthcare sector since its plunge in July 2025. UNH's reaffirmed 2025 guidance and constructive Medicare Advantage star ratings support conviction in its earnings recovery and long-term outlook. Based on the forecasted 2027 earnings outlook, the market may not have fully upgraded its optimism on the stock, paving the way for investors to consider doubling down.
Read More
Billionaire Investors Seem to Love This Stock the Most
Published: September 22, 2025 by: 24/7 Wall Street
Sentiment: Positive
Billionaire investors were quite active in the second quarter, with many of the big names going after a relatively narrow basket of stocks.
Read More
UnitedHealth: This Rally Is Lacking Substance; Sell Now
Published: September 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Rising medical cost ratios are expected to worsen in 2026, and recent regulations limit pricing gains, pressuring gross margins. Delayed data on superinvestors' buys is not a sufficient reason for becoming bullish on UNH, especially as there is no major bullish improvement on the fundamentals. Broadening scope of DoJ probes into the pharmacy benefit management business adds another risk wildcard.
Read More
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
U.S. politician makes super suspicious UnitedHealth stock trade
Published: September 16, 2025 by: Finbold
Sentiment: Neutral
United States Representative Lisa McClain has disclosed a purchase of UnitedHealth (NYSE: UNH) stock during a period of strong gains for the equity.
Read More
UnitedHealth (UNH) Is Considered a Good Investment by Brokers: Is That True?
Published: September 15, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Will UnitedHealth's Push for Access to Trump Calm Investor Jitters?
Published: September 15, 2025 by: Zacks Investment Research
Sentiment: Neutral
UNH doubles lobbying spend, reshapes legal team and seeks Trump access amid regulatory risks.
Read More
Why I'm Buying More UnitedHealth Than Centene
Published: September 12, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group stands out as the preferred pick over Centene due to scale, diversification, and higher profitability. UNH's integrated model and Optum platform provide more growth avenues and resilience compared to CNC's focus on government-sponsored programs. While CNC trades at a discount, UNH's stronger margins, return on equity, and diversified revenue streams justify its premium valuation.
Read More
UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.
Read More
UnitedHealth: Momentum Completes The Bullish Puzzle
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Positive
Trying to time the market with falling knives like UnitedHealth—which it was in the spring and summer—was extremely risky, so I chose to wait for momentum to return. Valuation metrics are attractive, with forward P/E and P/S ratios far below historical averages, making UNH a compelling value due to rock-solid fundamentals. Yesterday's reiteration of the EPS outlook by the management is crucial, as it underscores that the headwinds are temporary and their adverse effects are unlikely to persist for long.
Read More
At $350, Is UNH Stock Beaten Down And Ready To Bounce?
Published: September 10, 2025 by: Forbes
Sentiment: Positive
UnitedHealth Group (NYSE: UNH) jumped 8% on September 9, 2025, after the company said it is on track to meet its Medicare Advantage enrollment goals. The update eased investor concerns that the insurer could miss these critical targets amid ongoing operational challenges.
Read More
Tepper's 1,300% Leap Into UnitedHealth Stock Chaos Looked Crazy—Until It Didn't
Published: September 10, 2025 by: Benzinga
Sentiment: Positive
David Tepper's bold second-quarter buying spree in UnitedHealth Group Inc. UNH is already paying off. The billionaire hedge fund manager's Appaloosa Management increased its stake in the health insurance giant by a staggering 1,300% last quarter, turning a once-minor position into his fund's second-largest holding.
Read More
UNH "Remarkable Story:" Road to Recovery Ahead After Reaffirming FY25 EPS Guidance
Published: September 09, 2025 by: Schwab Network
Sentiment: Positive
UnitedHealth (UNH) remains more than 40% off all-time highs but is also about 50% off 52-week lows. George Tsilis says the company reaffirming EPS guidance gave investors a strong signal to take on shares.
Read More
Why UnitedHealth Group Stock Soared on Tuesday
Published: September 09, 2025 by: Investopedia
Sentiment: Positive
UnitedHealth Group (UNH) was the best-performing stock in the Dow Jones Industrial Average and the S&P 500 on Tuesday after the health care giant said the vast majority of its Medicare Advantage enrollees are likely to qualify for bonus payments from the federal government.
Read More
UnitedHealth makes investors like Warren Buffett happy by saying business is fine
Published: September 09, 2025 by: Market Watch
Sentiment: Positive
UnitedHealth's stock is surging, which is giving a nice boost to Warren Buffett's new 5-million-share stake in the health insurer.
Read More
Top Stock Movers Now: UnitedHealth Group, Fox, Freeport-McMoRan, and More
Published: September 09, 2025 by: Investopedia
Sentiment: Negative
The Dow, S&P 500, and Nasdaq were little changed at midday Tuesday following a report showing weaker-than-anticipated job growth. That raised speculation the Federal Reserve could move next week to cut interest rates more than previously thought.
Read More
UnitedHealth Group stock climbs on outlook confirmation
Published: September 09, 2025 by: Proactive Investors
Sentiment: Positive
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) shares moved up 4% to about $333 in late-morning trading on Tuesday after the health insurer reaffirmed its full-year 2025 financial guidance. The company confirmed its 2025 forecast of adjusted earnings of at least $16 per share with revenue in the range of $445.5 billion to $448 billion.
Read More
UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?
Published: September 09, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.
Read More
UnitedHealth stock rising from the dead, posts further gains
Published: September 09, 2025 by: Finbold
Sentiment: Neutral
UnitedHealth Group (NYSE: UNH) shares are showing signs of life after months of punishing declines, with the stock climbing in pre-market trading on September 9.
Read More
UnitedHealth & AI: Can Technology Redefine Healthcare Efficiency?
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH is leveraging AI to streamline insurance and care delivery, aiming to boost efficiency and improve patient outcomes.
Read More
3 Stocks Billionaire David Tepper Just Scooped Up
Published: September 08, 2025 by: 24/7 Wall Street
Sentiment: Positive
Billionaire investment legend David Tepper was quite busy in the second quarter, as he added to his stake in a number of intriguing firms, many of which seem to trade at far less than the market multiple.
Read More
Cyberattack Hangover: Senators Question UnitedHealth's Loan Playbook
Published: September 02, 2025 by: Zacks Investment Research
Sentiment: Negative
Senators question UNH over tough loan repayment demands post-cyberattack, adding to regulatory and cost pressures.
Read More
UnitedHealth: A Healthcare Giant To Hold For Years
Published: September 02, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth is a dominant, profitable healthcare leader trading at a significant discount after a 47% decline, with most risks already priced in. Despite near-term EPS pressure from rising medical costs, revenue growth remains strong and a turnaround is likely as cost headwinds subside. The stock offers a compelling 2.85% dividend yield, robust payout history, and consistent double-digit dividend growth, making it attractive for income investors.
Read More
Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Why Is UnitedHealth (UNH) Up 14.2% Since Last Earnings Report?
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?
Read More
Not Just Medicare, UnitedHealth's Optum Rx Gets Its Own DOJ Checkup
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Negative
UNH faces a widened DOJ probe, covering Optum Rx and physician payments, as rising medical costs pressure its business.
Read More
About UnitedHealth Group Incorporated (UNH)
- IPO Date 1984-10-17
- Website https://www.unitedhealthgroup.com
- Industry Medical - Healthcare Plans
- CEO Stephen J. Hemsley
- Employees 400000